Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
13.20
+0.16 (1.23%)
At close: Jun 27, 2025, 4:00 PM
13.36
+0.16 (1.21%)
After-hours: Jun 27, 2025, 6:20 PM EDT
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$28.78
Upside
+118.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +165.15% | May 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +127.27% | May 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $38 | Buy | Initiates | $38 | +187.88% | Mar 31, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +112.12% | Mar 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $27 | Buy | Initiates | $27 | +104.55% | Mar 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +112.12% | Nov 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $11 → $26 | Hold → Buy | Upgrades | $11 → $26 | +96.97% | Sep 19, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +150.00% | Sep 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $20 → $35 | Buy | Maintains | $20 → $35 | +165.15% | Sep 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +81.82% | Sep 11, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $13 → $19 | Strong Buy | Maintains | $13 → $19 | +43.94% | Sep 11, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +51.52% | Sep 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +6.06% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $14 | Buy | Initiates | $14 | +6.06% | Jul 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.